EMEA VP, Molecular Diagnostics Growth & P&L Leader

Hartmann Young Limited; España; Presencial; EUR 350.000 - 550.000; Jornada completa

Descripción de la vacante

Hartmann Young Limited is partnering with a global Molecular Diagnostics and Life Sciences company to appoint a VP / General Manager, EMEA. This role will own the EMEA strategy, P&L, and overall business performance, while leading regional teams to foster accountability and a customer-focused culture.

You will drive growth through direct sales, distribution channels, and strategic partnerships across multiple European markets, translating strategy into execution and aligning priorities with

Formación

• Senior commercial or general management experience within Molecular Diagnostics, IVD or Life Sciences.
• A strong track record of P&L ownership $200M+ and delivering profitable growth.
• Experience leading teams across multiple European and wider EMEA markets.
• Strong understanding of direct and distributor-led commercial models.
• Ability to translate strategy into execution and develop high-performing leadership teams.

Responsabilidades

• Own the EMEA strategy, P&L and overall business performance.
• Lead and develop regional teams, building a culture of accountability, collaboration and customer focus.
• Drive growth across direct sales, distribution channels and strategic partnerships.
• Identify opportunities for market expansion and strengthen relationships with key customers.
• Partner with global leadership to align regional priorities with the wider business strategy.

Conocimientos

P&L ownership

Leadership

Strategy execution

Descripción del empleo

Hartmann Young Limited is partnering with a global Molecular Diagnostics and Life Sciences company to appoint a VP / General Manager, EMEA. This role will own the EMEA strategy, P&L, and overall business performance, while leading regional teams to foster accountability and a customer-focused culture.

You will drive growth through direct sales, distribution channels, and strategic partnerships across multiple European markets, translating strategy into execution and aligning priorities with